Xanthine dehydrogenases from various sources are proteins of molecular mass 300 kDa and are composed of two identical independent subunits; each subunit contains one molybdopterin, two non-identical 2Fe/2S centres and FAD [ 1,2]. T h e mammalian enzyme exists originally as xanthine dehydrogenase, but is converted into xanthine oxidase during extraction or purification procedures [3]. Xanthine dehydrogenase is characterized by high xanthine/NAD+ activity and low xanthine/Oz activity, whereas xanthine oxidase is characterized by high xanthine/OZ activity and negligible xanthine/NAD+ activity. the assignment of the 20 kDa fragment to the N-terminal portion, the 85 kDa fragment to the C-terminal portion and the 40 kDa fragment to the intermediate portion. The chicken enzyme was also cleaved into three fragments in a similar way, but the enzyme is not converted into the oxidase [9] . Comparative alignment of the deduced protein sequences has been attempted in order to identify the possible locations of the redox active centres. Sequence comparison [5-91 and chemical-modification studies suggested that each redox centre is located in different domains, i.e. the two iron-sulphur centres are in the 20 kDa domain, the FAD is in the 40 kDa domain and the molybdopterin is in the 85 kDa domain [6,9]. These conclusions are consistent with the results obtained from X-ray-crystallographic analysis of aldehyde oxidoreductase from Desulfovibrio g&as which is another molybdenum-containing iron-sulphur protein [ 1 11. There is high sequence homology between xanthine oxidase and aldehyde oxidoreductase in the N-terminal and c-terminal regions, which were identified as the iron-sulphur-centre-binding sites and the molybdenum-binding site respectively. Thus the intermediate portion of the xanthine-oxidizing enzyme, which is lacking in aldehyde oxidase, is strongly implicated to be the FAD-binding site.
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Mechanism of conversion of xanthine dehydrogenase into xanthine oxidase
Xanthine dehydrogenases from various sources are proteins of molecular mass 300 kDa and are composed of two identical independent subunits; each subunit contains one molybdopterin, two non-identical 2Fe/2S centres and FAD [ 1,2].
T h e mammalian enzyme exists originally as xanthine dehydrogenase, but is converted into xanthine oxidase during extraction or purification procedures [3]. Xanthine dehydrogenase is characterized by high xanthine/NAD+ activity and low xanthine/Oz activity, whereas xanthine oxidase is characterized by high xanthine/OZ activity and negligible xanthine/NAD+ activity. . These conclusions are consistent with the results obtained from X-ray-crystallographic analysis of aldehyde oxidoreductase from Desulfovibrio g&as which is another molybdenum-containing iron-sulphur protein [ 1 11. There is high sequence homology between xanthine oxidase and aldehyde oxidoreductase in the N-terminal and c-terminal regions, which were identified as the iron-sulphur-centre-binding sites and the molybdenum-binding site respectively. Thus the intermediate portion of the xanthine-oxidizing enzyme, which is lacking in aldehyde oxidase, is strongly implicated to be the FAD-binding site.
As described above, chicken liver xanthine dehydrogenase has never been known to be con-verted into xanthine oxidase, in striking contrast with the mammalian xanthine dehydrogenase. In order to discover the structural differences between the chicken and rat enzymes, we constructed several recombinant enzymes using a cDNA expression system of baculovirus/insect cell. The expressed rat enzyme with all three domains exhibited dehydrogenase-type properties with high activity toward NAD' but low activity toward 02. This enzyme was readily converted into oxidase by treatment with dithiodipyridine, indicating that the expressed enzyme has the property of the native enzyme purified from rat liver. As described above, the chicken enzyme has an additional cysteine-rich fragment composed of 23 amino acids in the N-terminal region. T h e chimaeric enzyme with insertion of the fragment into the rat enzyme had the same property as the wild-type rat liver xanthine dehydrogenase. Another chimaeric enzyme was constructed from recombinant rat enzyme by replacing its flavin domain with that of chicken. This was a typical xanthine dehydrogenase type and could not be converted into xanthine oxidase by modification with dithiodipyridine. These results clearly indicate that the differences in properties between the rat and chicken enzymes do not exist in either the N-terminal or the C-terminal domain but exist in the intermediate flavin-containing domain. Many lines of evidence for differences in conformation around the flavin have been provided by active-site probe studies using artificial flavins with an ionizable residue at the 6-or 8-position [12-141. When [14] were replaced by 6-or 8-SH-FAD, the flavin was bound as the neutral form. On the other hand, xanthine oxidases from rat liver and bovine milk bind to this flavin in the benzoquinoid anionic form [12-141. As the pKvalue of free 8-SH-FAD is 3.8 [ 151, the dehydrogenase perturbs the pK of the ionizable substituent by more than 4 units. In the case of the milk enzyme, the pK has been determined as 5.0 in xanthine oxidase and 9.0 in xanthine dehydrogenase [ 141. Such perturbation of the pK suggests a strong negative charge in the flavin-binding site of the dehydrogenase, which is absent from xanthine oxidase. T h e differences in the two forms are restricted largely to the absence of an NAD+-binding site as well as to the destabilization of the flavin semiquinone in the oxidase resulting from the conformational changes in the flavin domain.
Role of xanthine oxidase in recirculation injury
As xanthine oxidase produces 0;' as well as H202, the enzyme has been proposed to be responsible for recirculation injury [ 161. According to this hypothesis, the enzyme, which exists in endothelial cells, is converted from the dehydrogenase into the oxidase during ischaemia. Upon recirculation, xanthine oxidase oxidizes accumulated hypoxanthine to produce toxic oxy radicals which cause tissue damage. Certainly, many workers have reported that large amounts of hypoxanthine are released during ischaemia, consequent on adenine nucleotide depletion. T h e involvement of 0;' in the processes of membrane lysis [ 171 and the existence of xanthine oxidase in the endothelial cell [18] appeared to support the hypothesis of a role for xanthine oxidase in reperfusion injury. The initial evidence for the conversion into the oxidase was based on experiments using intestine [ 161, which stimulated much interest in this proposed mechanism of reperfusion injury. T h e hypothesis has since been extended to other organs such as heart, kidney, lung and brain [ 19,201. T h e biggest problem, however, is whether the enzyme actually exists in the human organs that may suffer reperfusion injury. It has been reported that no significant enzyme activity is present in human heart [21]. However, in recent work using immunohistochemical techniques the xanthine oxidase antigen was detected in the endothelial lining cells from various organs including heart, brain and kidney [22]. Another problem is whether the dehydrogenase converted into the oxidase during ischaemia. Normally, 20% of the enzyme exists as the oxidase, mostly in a reversible form, and 80% as the dehydrogenase. Although without NAD+ xanthine dehydrogenase can produce large amounts of 0,' by oxidation of xanthine as substrate [23], this activity should be inhibited by the excess NAD' found in the cell. Many experimental results have shown that the conversion from xanthine dehydrogenase into the oxidase by proteolysis is very slow and limited to only a portion of the total enzyme [24] . Thus the situation is not as simple as originally envisaged. It is possible, however, that accumulated NADH during ischaemia inhibits only the dehydrogenase (Ki N low6 M), and therefore accumulated hypoxanthine could be oxidized by the oxidase in larger amounts than normal, and consequently oxy radical species could be formed in larger Volume 25
Possible mechanism of post-ischaemic reperfusion injury
Hypoxanthine and N A D H are accumulated during ischaemia. As NADH inhibits xanthine dehydrogenase, accumulated hypoxanthine could be oxidized in larger amounts than normal by the oxidase which exists normally in some portions. NADH oxidation by the dehydrogenase could also product 0;. The 0;' reacts rapidly with NO to give ONOO-. [23, 24] . It should be noted that NO, the importance of which in vascular-tonus relaxation has been recognized [25] and which may be derived from the same cell, can react much more rapidly with 0;' than previously reported [26] . Therefore a small increase in 0,' may diminish the physiological role of NO in vasodilation of the organ, and resultant ONOOcould also be toxic to the tissue. If the reaction of 0;' with NO is faster than the reaction of 0;' with superoxide dismutase, it may be difficult to detect 0;' by the spin trap method. It was recently noticed that xanthine oxidase itself can be inactivated by NO. Thus the problem is more complex than originally envisaged and remains to be clarified.
T h e molybdoenzyme, xanthine oxidoreductase (XOR), has been much studied, largely because of its ready availability on a large scale from cows' milk [l] . It catalyses the oxidation of a wide range of substrates, most notably hypoxanthine and xanthine, generating xanthine and uric acid respectively, in the process of purine catabolism. T h e enzyme is a homodimer of 150 kDa subunits and exists in two interconvertible forms, xanthine dehydrogenase (XDH; EC 1.1.1.204) and xanthine oxidase (XO; EC 1.1.3.22). XDH preferentially reduces NAD', whereas XO does not reduce NAD', preferring molecular oxygen. Reduction of oxygen by either form of the enzyme yields 0;' and H202, and it is the capacity to generate such reactive oxygen species (ROS) that has led to a great deal of interest in XOR as a pathogenic factor in many instances of ischaemia-reperfusion injury [2] . More recently, an increasing body of evidence suggests a role for ROS in normal signal transduction [3-51.
The commonly cited mechanism involving XOR in ischaemia-reperfusion injury [6,7] can be summarized as follows. During ischaemia the cell's energy charge falls and transmembrane ion gradients are dissipated, leading to elevated cytosolic concentrations of CaZ+. This in turn activates a protease that irreversibly converts XDH, predominant in vi'uo, into XO. Concurrently, depletion of cellular ATP leads to AMP, which is catabolized successively to adenosine, inosine Abbreviations used: ROS, reactive oxygen species; XDH, xanthine dehydrogenase; XO, xanthine oxidase; XOR, xanthine oxidoreductase. and finally hypoxanthine. Hypoxanthine accumulates and serves as reducing substrate for the newly converted XO, which, on readmission of molecular oxygen to the tissues, catalyses the generation of 0;' and H202. This sequence of events is summarized in Figure 1 .
The above pathogenic mechanism is based on the properties of the well-characterized bovine milk [l], rat [8] and chicken [9] liver enzymes, and, although results obtained in experimental animal systems are commonly extrapolated, at least implicitly, to humans, relatively little is known about the human enzyme.
We have purified human XOR from breast milk and found it to have surprising properties. In a preparation procedure [lo] refined from that originally reported [ll] , frozen breast milk is thawed and the separated cream is washed to remove membrane-associated XOR. T h e enzyme is solubilized by addition of butanol and subjected to (NH4)zS04 fractionation before sequential heparin and ion-exchange chromatography. By these means, 10-20 mg of human XOR are obtained from 1500 ml of breast milk. These yields are comparable with those obtained by similar procedures from fresh cows' milk [lo] .
T h e resulting human XOR is highly purified. On SDS/PAGE it runs as a single band, corresponding to approx. 150 kDa. The UV/visible spectrum is very similar to that of pure bovine milk enzyme [ l ] and, like pure enzyme from other sources, shows a protein (Azxn) to Aavin (A45n) ratio of 5.0-5.5 [l] . Unexpectedly, the activity towards most reducing substrates is very low, representing in the case of xanthine only 2-396 that of purified bovine milk enzyme
